BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodgers GL, Arguedas A, Cohen R, Dagan R. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 2009;27:3802-10. [PMID: 19446378 DOI: 10.1016/j.vaccine.2009.04.021] [Cited by in Crossref: 94] [Cited by in F6Publishing: 77] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Madhi SA, Govender N, Dayal K, Devadiga R, Van Dyke MK, van Niekerk N, Cutland CL, Adrian PV, Nunes MC. Bacterial and Respiratory Viral Interactions in the Etiology of Acute Otitis Media in HIV-infected and HIV-uninfected South African Children. Pediatr Infect Dis J 2015;34:753-60. [PMID: 25923426 DOI: 10.1097/INF.0000000000000733] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
2 Marès Bermúdez J, van Esso Arbolave D, Moreno-pérez D, Merino Moína M, Álvarez García F, Cilleruelo Ortega M, Arístegui Fernández J, Ortigosa del Castillo L, Ruiz-contreras J, Barrio Corrales F, González-hachero J. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2011. Anales de Pediatría 2011;74:132.e1-132.e19. [DOI: 10.1016/j.anpedi.2010.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
3 Laferriere C. The immunogenicity of pneumococcal polysaccharides in infants and children: a meta-regression. Vaccine 2011;29:6838-47. [PMID: 21816198 DOI: 10.1016/j.vaccine.2011.07.097] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
4 Kung YH, Chiu NC, Lee KS, Chang L, Huang DT, Huang FY, Hsieh YC, Huang LM, Chi H. Bacterial etiology of acute otitis media in the era prior to universal pneumococcal vaccination in Taiwanese children. J Microbiol Immunol Infect 2014;47:239-44. [PMID: 24080520 DOI: 10.1016/j.jmii.2013.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
5 Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL; Pneumococcal Carriage Group. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines 2012;11:841-55. [PMID: 22913260 DOI: 10.1586/erv.12.53] [Cited by in Crossref: 404] [Cited by in F6Publishing: 365] [Article Influence: 40.4] [Reference Citation Analysis]
6 Somech I, Dagan R, Givon-Lavi N, Porat N, Raiz S, Leiberman A, Puterman M, Peled N, Greenberg D, Leibovitz E. Distribution, dynamics and antibiotic resistance patterns of Streptococcus pneumoniae serotypes causing acute otitis media in children in southern Israel during the 10 year-period before the introduction of the 7-valent pneumococcal conjugate vaccine. Vaccine 2011;29:4202-9. [PMID: 21497634 DOI: 10.1016/j.vaccine.2011.03.103] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
7 Marès Bermúdez J, van Esso Arbolave D, Arístegui Fernández J, Ruiz Contreras J, González Hachero J, Merino Moína M, Barrio Corrales F, Álvarez García F, Cilleruelo Ortega M, Ortigosa del Castillo L, Moreno Pérez D. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2010. Anales de Pediatría 2010;72:433.e1-433.e17. [DOI: 10.1016/j.anpedi.2010.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
8 Rodgers GL, Klugman KP. The future of pneumococcal disease prevention. Vaccine 2011;29 Suppl 3:C43-8. [PMID: 21896352 DOI: 10.1016/j.vaccine.2011.07.047] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
9 Falup-pecurariu O, Leibovitz E, Mercas A, Bleotu L, Zavarache C, Porat N, Dagan R, Greenberg D. Pneumococcal acute otitis media in infants and children in central Romania, 2009–2011: microbiological characteristics and potential coverage by pneumococcal conjugate vaccines. International Journal of Infectious Diseases 2013;17:e702-6. [DOI: 10.1016/j.ijid.2013.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
10 Campanero C, Muñoz-Atienza E, Diep DB, Feito J, Arbulu S, Del Campo R, Nes IF, Hernández PE, Herranz C, Cintas LM. Biochemical, genetic and transcriptional characterization of multibacteriocin production by the anti-pneumococcal dairy strain Streptococcus infantarius LP90. PLoS One 2020;15:e0229417. [PMID: 32134941 DOI: 10.1371/journal.pone.0229417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Weil Olivier C. Ten years of experience with the pneumococcal conjugate 7-valent vaccine in children. Médecine et Maladies Infectieuses 2013;43:309-21. [DOI: 10.1016/j.medmal.2013.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Gene A, Amo ED, Iñigo M, Monsonis M, Pallares R, Muñoz-almagro C. Pneumococcal Serotypes Causing Acute Otitis Media Among Children in Barcelona (1992–2011): Emergence of the Multiresistant Clone ST320 of Serotype 19A. Pediatric Infectious Disease Journal 2013;32:e128-33. [DOI: 10.1097/inf.0b013e31827c54dc] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
13 Principi N, Baggi E, Esposito S. Prevention of acute otitis media using currently available vaccines. Future Microbiology 2012;7:457-65. [DOI: 10.2217/fmb.12.23] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
14 Rijkers GT. Fixing a Hole: Preventing Pneumococcal Pneumonia by Vaccination. Front Immunol 2016;7:349. [PMID: 27679637 DOI: 10.3389/fimmu.2016.00349] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Klugman KP, Black S, Dagan R, Malley R, Whitney CG. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. Vaccines. Elsevier; 2013. pp. 504-41. [DOI: 10.1016/b978-1-4557-0090-5.00032-x] [Cited by in Crossref: 7] [Article Influence: 0.8] [Reference Citation Analysis]
16 Parra MM, Aguilar GM, Echaniz-aviles G, Rionda RG, de Los Angeles Meza Estrada M, Cervantes Y, Pirçon J, Van Dyke MK, Colindres RE, Hausdorff WP. Bacterial etiology and serotypes of acute otitis media in Mexican children. Vaccine 2011;29:5544-9. [DOI: 10.1016/j.vaccine.2011.04.128] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
17 Prymula R, Chlibek R, Ivaskeviciene I, Mangarov A, Mészner Z, Perenovska P, Richter D, Salman N, Šimurka P, Tamm E, Tešović G, Urbancikova I, Usonis V. Paediatric pneumococcal disease in Central Europe. Eur J Clin Microbiol Infect Dis 2011;30:1311-20. [DOI: 10.1007/s10096-011-1241-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
18 Pan C, Yue H, Zhu L, Ma GH, Wang HL. Prophylactic vaccine delivery systems against epidemic infectious diseases. Adv Drug Deliv Rev 2021;176:113867. [PMID: 34280513 DOI: 10.1016/j.addr.2021.113867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
19 Ovnat Tamir S, Roth Y, Goldfarb A, Grotto I, Marom T. Severity of pneumococcal versus non-pneumococcal acute otitis media in children. Clin Otolaryngol 2015;40:370-7. [PMID: 25644105 DOI: 10.1111/coa.12384] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Yu J, Salamon D, Marcon M, Nahm MH. Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients. J Clin Microbiol 2011;49:534-8. [PMID: 21123535 DOI: 10.1128/JCM.01827-10] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
21 Rosch JW, Iverson AR, Humann J, Mann B, Gao G, Vogel P, Mina M, Murrah KA, Perez AC, Edward Swords W, Tuomanen EI, McCullers JA. A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media. EMBO Mol Med 2014;6:141-54. [PMID: 24408968 DOI: 10.1002/emmm.201202150] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
22 Guo P, Zhang J, Tsai S, Li B, Lo SC. Developing Peptide Mimotopes of Capsular Polysaccharides and Lipopolysaccharides Protective Antigens of Pathogenic Burkholderia Bacteria. Monoclon Antib Immunodiagn Immunother 2016;35:125-34. [PMID: 27328059 DOI: 10.1089/mab.2015.0073] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Brooks LRK, Mias GI. Streptococcus pneumoniae's Virulence and Host Immunity: Aging, Diagnostics, and Prevention. Front Immunol 2018;9:1366. [PMID: 29988379 DOI: 10.3389/fimmu.2018.01366] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 16.3] [Reference Citation Analysis]
24 Naranjo L, Suarez JA, DeAntonio R, Sanchez F, Calvo A, Spadola E, Rodríguez N, Andrade O, Bertuglia F, Márquez N, Castrejon MM, Ortega-Barria E, Colindres RE. Non-capsulated and capsulated Haemophilus influenzae in children with acute otitis media in Venezuela: a prospective epidemiological study. BMC Infect Dis 2012;12:40. [PMID: 22335965 DOI: 10.1186/1471-2334-12-40] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
25 Dagan R, Pelton S, Bakaletz L, Cohen R. Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease. Lancet Infect Dis 2016;16:480-92. [PMID: 27036355 DOI: 10.1016/S1473-3099(15)00549-6] [Cited by in Crossref: 83] [Cited by in F6Publishing: 35] [Article Influence: 13.8] [Reference Citation Analysis]
26 Castañeda E, Agudelo CI, De Antonio R, Rosselli D, Calderón C, Ortega-Barria E, Colindres RE. Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010. BMC Infect Dis 2012;12:124. [PMID: 22639955 DOI: 10.1186/1471-2334-12-124] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
27 Vojtek I, Nordgren M, Hoet B. Impact of pneumococcal conjugate vaccines on otitis media: A review of measurement and interpretation challenges. International Journal of Pediatric Otorhinolaryngology 2017;100:174-82. [DOI: 10.1016/j.ijporl.2017.07.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
28 Hasegawa J, Mori M, Ohnishi H, Tsugawa T, Hori T, Yoto Y, Tsutsumi H. Pneumococcal vaccination reduces the risk of community-acquired pneumonia in children. Pediatr Int 2017;59:316-20. [PMID: 27588365 DOI: 10.1111/ped.13157] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Wahyono DJ, Khoeri MM, Darmawan AB, Wijayanti SPM, Mumpuni A, Nawangtantri G, Kusdaryanto WD, Salsabila K, Safari D. Nasopharyngeal carriage rates and serotype distribution of Streptococcus pneumoniae among school children with acute otitis media in Central Java, Indonesia. Access Microbiol 2021;3:000249. [PMID: 34595398 DOI: 10.1099/acmi.0.000249] [Reference Citation Analysis]
30 Xu J, Dai W, Wang Z, Chen B, Li Z, Fan X. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae. Clin Vaccine Immunol 2011;18:75-81. [PMID: 21047997 DOI: 10.1128/CVI.00263-10] [Cited by in Crossref: 60] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
31 Kempf M, Varon E, Lepoutre A, Gravet A, Baraduc R, Brun M, Chardon H, Cremniter J, Croizé J, Dalmay F, Demachy MC, Fosse T, Grelaud C, Hadou T, Hamdad F, Koeck JL, Luce S, Mermond S, Patry I, Péchinot A, Raymond J, Ros A, Segonds C, Soullié B, Tandé D, Vergnaud M, Vernet-Garnier V, Wallet F, Gutmann L, Ploy MC, Lanotte P. Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network. Clin Microbiol Infect 2015;21:35-42. [PMID: 25636925 DOI: 10.1016/j.cmi.2014.08.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
32 Reinert RR, Paradiso P, Fritzell B. Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe. Expert Rev Vaccines 2010;9:229-36. [PMID: 20218848 DOI: 10.1586/erv.10.6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
33 Domenech M, Araújo-Bazán L, García E, Moscoso M. In vitro biofilm formation by Streptococcus pneumoniae as a predictor of post-vaccination emerging serotypes colonizing the human nasopharynx. Environ Microbiol 2014;16:1193-201. [PMID: 24373136 DOI: 10.1111/1462-2920.12370] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
34 Gladstone RA, Jefferies JM, Faust SN, Clarke SC. Continued control of pneumococcal disease in the UK – the impact of vaccination. Journal of Medical Microbiology 2011;60:1-8. [DOI: 10.1099/jmm.0.020016-0] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
35 Varghese R, Veeraraghavan B. Decoding the Penicillin Resistance of Streptococcus pneumoniae for Invasive and Noninvasive Infections. Microbial Drug Resistance 2021;27:942-50. [DOI: 10.1089/mdr.2020.0233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Fu J, Li L, Liang Z, Xu S, Lin N, Qin P, Ye X, McGrath E. Etiology of acute otitis media and phenotypic-molecular characterization of Streptococcus pneumoniae isolated from children in Liuzhou, China. BMC Infect Dis 2019;19:168. [PMID: 30770718 DOI: 10.1186/s12879-019-3795-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
37 Mayanskiy N, Alyabieva N, Ponomarenko O, Pakhomov A, Kulichenko T, Ivanenko A, Lazareva M, Lazareva A, Katosova L, Namazova-Baranova L, Baranov A. Bacterial etiology of acute otitis media and characterization of pneumococcal serotypes and genotypes among children in Moscow, Russia. Pediatr Infect Dis J 2015;34:255-60. [PMID: 25232779 DOI: 10.1097/INF.0000000000000554] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
38 Ding Y, Geng Q, Tao Y, Lin Y, Wang Y, Black S, Zhao G, Zhang T. Etiology and epidemiology of children with acute otitis media and spontaneous otorrhea in Suzhou, China. Pediatr Infect Dis J 2015;34:e102-6. [PMID: 25379833 DOI: 10.1097/INF.0000000000000617] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
39 Muciño-ortega E, Mould-quevedo JF, Farkouh R, Strutton D. Evaluación Económica de un Programa de Inmunización Infantil en México Basado en la Vacuna Neumocócica Conjugada 13-Valente. Value in Health 2011;14:S65-70. [DOI: 10.1016/j.jval.2011.05.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
40 Han SB, Kim JH, Kang JH, Ma SH, Kim CS, Kim KH, Kim HM, Choi YY. Recent epidemiology of Streptococcus pneumoniae in nasopharynxes of Korean children with acute otitis media. J Infect Chemother 2017;23:136-41. [PMID: 28024738 DOI: 10.1016/j.jiac.2016.10.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
41 Tregnaghi MW, Sáez-Llorens X, López P, Abate H, Smith E, Pósleman A, Calvo A, Wong D, Cortes-Barbosa C, Ceballos A, Tregnaghi M, Sierra A, Rodriguez M, Troitiño M, Carabajal C, Falaschi A, Leandro A, Castrejón MM, Lepetic A, Lommel P, Hausdorff WP, Borys D, Ruiz Guiñazú J, Ortega-Barría E, Yarzábal JP, Schuerman L; COMPAS Group. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial. PLoS Med 2014;11:e1001657. [PMID: 24892763 DOI: 10.1371/journal.pmed.1001657] [Cited by in Crossref: 164] [Cited by in F6Publishing: 147] [Article Influence: 20.5] [Reference Citation Analysis]
42 Couloigner V, Levy C, François M, Bidet P, Hausdorff WP, Pascal T, Boucherat M, Bingen E, Mariani P, Pierrot S, Bille E, Carbonnelle E, Varon E, Cohen R. Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels. Pediatr Infect Dis J 2012;31:154-8. [PMID: 21983212 DOI: 10.1097/INF.0b013e3182357c8d] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
43 Rodgers GL, Arguedas A, Cohen R, Dagan R. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740]. Vaccine 2009;27:5429-30. [PMID: 19643215 DOI: 10.1016/j.vaccine.2009.07.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Sierra A, Lopez P, Zapata MA, Vanegas B, Castrejon MM, Deantonio R, Hausdorff WP, Colindres RE. Non-typeable Haemophilus influenzae and Streptococcus pneumoniae as primary causes of acute otitis media in colombian children: a prospective study. BMC Infect Dis 2011;11:4. [PMID: 21208431 DOI: 10.1186/1471-2334-11-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
45 Zielnik-Jurkiewicz B, Bielicka A. Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure. Int J Pediatr Otorhinolaryngol 2015;79:2129-33. [PMID: 26454530 DOI: 10.1016/j.ijporl.2015.09.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
46 Vickers I, O'Flanagan D, Cafferkey M, Humphreys H. Multiplex PCR to determine Streptococcus pneumoniae serotypes causing otitis media in the Republic of Ireland with further characterisation of antimicrobial susceptibilities and genotypes. Eur J Clin Microbiol Infect Dis 2011;30:447-53. [PMID: 21076929 DOI: 10.1007/s10096-010-1108-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
47 Thomas JC, Figueira M, Fennie KP, Laufer AS, Kong Y, Pichichero ME, Pelton SI, Pettigrew MM. Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence. PLoS One 2011;6:e18649. [PMID: 21533186 DOI: 10.1371/journal.pone.0018649] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
48 Intakorn P, Sonsuwan N, Noknu S, Moungthong G, Pirçon JY, Liu Y, Van Dyke MK, Hausdorff WP. Haemophilus influenzae type b as an important cause of culture-positive acute otitis media in young children in Thailand: a tympanocentesis-based, multi-center, cross-sectional study. BMC Pediatr 2014;14:157. [PMID: 24947736 DOI: 10.1186/1471-2431-14-157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
49 Keller LE, Robinson DA, McDaniel LS. Nonencapsulated Streptococcus pneumoniae: Emergence and Pathogenesis. mBio 2016;7:e01792. [PMID: 27006456 DOI: 10.1128/mBio.01792-15] [Cited by in Crossref: 82] [Cited by in F6Publishing: 55] [Article Influence: 13.7] [Reference Citation Analysis]
50 Prymula R. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines. Vaccine 2009;27:4739-40. [DOI: 10.1016/j.vaccine.2009.05.098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
51 Setchanova LP, Kostyanev T, Alexandrova AB, Mitov IG, Nashev D, Kantardjiev T. Microbiological characterization of Streptococcus pneumoniae and non-typeable Haemophilus influenzae isolates as primary causes of acute otitis media in Bulgarian children before the introduction of conjugate vaccines. Ann Clin Microbiol Antimicrob 2013;12:6. [PMID: 23531034 DOI: 10.1186/1476-0711-12-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
52 Moore SE, Richards AA, Goldblatt D, Ashton L, Szu SC, Prentice AM. Early-life and contemporaneous nutritional and environmental predictors of antibody response to vaccination in young Gambian adults. Vaccine 2012;30:4842-8. [PMID: 22609011 DOI: 10.1016/j.vaccine.2012.05.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
53 Rubin JL, McGarry LJ, Strutton DR, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC. Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States. Vaccine 2010;28:7634-43. [PMID: 20883739 DOI: 10.1016/j.vaccine.2010.09.049] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
54 Bencina G, Fues Wahl H, Tsoumani E, Salomonsson S. Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: a systematic literature review. Hum Vaccin Immunother 2022;:1-11. [PMID: 35438039 DOI: 10.1080/21645515.2022.2060017] [Reference Citation Analysis]
55 Sabharwal V, Figueira M, Pelton SI, Pettigrew MM. Virulence of Streptococcus pneumoniae serotype 6C in experimental otitis media. Microbes Infect 2012;14:712-8. [PMID: 22414497 DOI: 10.1016/j.micinf.2012.02.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
56 Song JY, Nahm MH, Moseley MA. Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance. J Korean Med Sci 2013;28:4-15. [PMID: 23341706 DOI: 10.3346/jkms.2013.28.1.4] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
57 Arguedas A, Soley C, Abdelnour A. Prevenar experience. Vaccine 2011;29:C26-34. [DOI: 10.1016/j.vaccine.2011.06.104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
58 Klugman KP, Dagan R, Malley R, Whitney CG. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 773-815.e18. [DOI: 10.1016/b978-0-323-35761-6.00045-6] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
59 Ekinci E, Desmet S, Van Heirstraeten L, Mertens C, Wouters I, Beutels P, Verhaegen J, Malhotra-Kumar S, Theeten H; NPcarriage Group. Streptococcus pneumoniae Serotypes Carried by Young Children and Their Association With Acute Otitis Media During the Period 2016-2019. Front Pediatr 2021;9:664083. [PMID: 34291017 DOI: 10.3389/fped.2021.664083] [Reference Citation Analysis]
60 Seeberger PH, Pereira CL, Govindan S. Total synthesis of a Streptococcus pneumoniae serotype 12F CPS repeating unit hexasaccharide. Beilstein J Org Chem 2017;13:164-73. [PMID: 28228857 DOI: 10.3762/bjoc.13.19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
61 Wu Y, Zhang Q, Sales D, Bianco AE, Craig A. Vaccination with peptide mimotopes produces antibodies recognizing bacterial capsular polysaccharides. Vaccine 2010;28:6425-35. [PMID: 20674874 DOI: 10.1016/j.vaccine.2010.07.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
62 Andrade AL, Toscano CM, Minamisava R, Costa PS, Andrade JG. Pneumococcal disease manifestation in children before and after vaccination: what's new? Vaccine 2011;29 Suppl 3:C2-14. [PMID: 21896349 DOI: 10.1016/j.vaccine.2011.06.096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
63 Hasegawa J, Mori M, Showa S, Matsushima A, Ohnishi H, Tsugawa T, Yoto Y, Tsutsumi H. Pneumococcal vaccination reduced the risk of acute otitis media: Cohort study. Pediatr Int 2015;57:582-5. [PMID: 25615843 DOI: 10.1111/ped.12587] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
64 Negash AA, Asrat D, Abebe W, Hailemariam T, Gebre M, Aseffa A, Vaneechoutte M. Pneumococcal serotype 19A is the major cause of pediatric acute otitis media with ruptured tympanic membrane in Addis Ababa, Ethiopia, 5 years after the introduction of the ten-valent pneumococcal conjugate vaccine. Int J Pediatr Otorhinolaryngol 2019;126:109638. [PMID: 31442868 DOI: 10.1016/j.ijporl.2019.109638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Zangeneh TT, Baracco G, Al-Tawfiq JA. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections. Expert Rev Vaccines 2011;10:345-53. [PMID: 21434802 DOI: 10.1586/erv.11.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
66 Sheen YH, Rajagopalan G, Snapper CM, Kita H, Wi CI, Umaretiya PJ, Juhn YJ. Influence of HLA-DR polymorphism and allergic sensitization on humoral immune responses to intact pneumococcus in a transgenic mouse model. HLA 2016;88:25-34. [PMID: 27506953 DOI: 10.1111/tan.12851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Mills N, Best EJ, Murdoch D, Souter M, Neeff M, Anderson T, Salkeld L, Ahmad Z, Mahadevan M, Barber C, Brown C, Walker C, Walls T. What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination. J Paediatr Child Health 2015;51:300-6. [PMID: 25175818 DOI: 10.1111/jpc.12710] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
68 Olafsdottir TA, Lingnau K, Nagy E, Jonsdottir I. Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice. Infect Immun 2012;80:461-8. [PMID: 22025519 DOI: 10.1128/IAI.05801-11] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
69 Vadlamudi NK, Saatchi A, Patrick DM, Rose C, Sadatsafavi M, Marra F. Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada. J Antimicrob Chemother 2021:dkab167. [PMID: 34021757 DOI: 10.1093/jac/dkab167] [Reference Citation Analysis]
70 Dinleyici EC, Yargic ZA. Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine. Expert Review of Vaccines 2014;8:977-86. [DOI: 10.1586/erv.09.68] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
71 Chen Y, Hsieh Y, Huang Y, Chiu C. Clinical manifestations and microbiology of acute otitis media with spontaneous otorrhea in children. Journal of Microbiology, Immunology and Infection 2013;46:382-8. [DOI: 10.1016/j.jmii.2013.04.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
72 Tai SS. Streptococcus pneumoniae Serotype Distribution and Pneumococcal Conjugate Vaccine Serotype Coverage among Pediatric Patients in East and Southeast Asia, 2000-2014: a Pooled Data Analysis. Vaccines (Basel) 2016;4:E4. [PMID: 26907356 DOI: 10.3390/vaccines4010004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
73 Schaar V, Nordström T, Mörgelin M, Riesbeck K. Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob Agents Chemother 2011;55:3845-53. [PMID: 21576428 DOI: 10.1128/AAC.01772-10] [Cited by in Crossref: 77] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
74 Gülhan B, Kanik-Yuksek S, Ozkaya-Parlakay A. Mastoiditis with Streptococcus pneumoniae serotype 19A in one-dose PCV13 vaccinated three-month-old infant. Hum Vaccin Immunother 2019;15:2917-8. [PMID: 31348728 DOI: 10.1080/21645515.2019.1627823] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Ciapponi A, Lee A, Bardach A, Glujovsky D, Rey-ares L, Luisa Cafferata M, Valanzasca P, García Martí S. Interchangeability between Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-Analysis. Value in Health Regional Issues 2016;11:24-34. [DOI: 10.1016/j.vhri.2015.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
76 Laufer AS, Thomas JC, Figueira M, Gent JF, Pelton SI, Pettigrew MM. Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine. Vaccine 2010;28:2450-7. [PMID: 20067753 DOI: 10.1016/j.vaccine.2009.12.078] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
77 Agrawal S, Nadel S. Acute bacterial meningitis in infants and children: epidemiology and management. Paediatr Drugs 2011;13:385-400. [PMID: 21999651 DOI: 10.2165/11593340-000000000-00000] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
78 van der Linden M, Reinert RR. Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany. Eur J Clin Microbiol Infect Dis 2010;29:749-54. [PMID: 20432051 DOI: 10.1007/s10096-010-0945-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
79 Weishaupt MW, Matthies S, Hurevich M, Pereira CL, Hahm HS, Seeberger PH. Automated glycan assembly of a S. pneumoniae serotype 3 CPS antigen. Beilstein J Org Chem 2016;12:1440-6. [PMID: 27559395 DOI: 10.3762/bjoc.12.139] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
80 Fletcher MA, Fritzell B. Pneumococcal conjugate vaccines and otitis media: an appraisal of the clinical trials. Int J Otolaryngol 2012;2012:312935. [PMID: 22701486 DOI: 10.1155/2012/312935] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
81 Xu J, Dai W, Chen B, Fan X. Mucosal Immunization with PsaA Protein, Using Chitosan as a Delivery System, Increases Protection Against Acute Otitis Media and Invasive Infection by Streptococcus pneumoniae. Scand J Immunol 2015;81:177-85. [DOI: 10.1111/sji.12267] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
82 Fenoll A, Aguilar L, Vicioso MD, Gimenez MJ, Robledo O, Granizo JJ. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009. BMC Infect Dis 2011;11:239. [PMID: 21910891 DOI: 10.1186/1471-2334-11-239] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
83 Shakrin NNSM, Masri SN, Taib NM, Nordin SA, Jamal F, Desa MNM. Genotypic characterization of Malaysian human isolates of Streptococcus pneumoniae from carriage and clinical sources. Comparative Immunology, Microbiology and Infectious Diseases 2014;37:347-54. [DOI: 10.1016/j.cimid.2014.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]